P731.F - Medexus Pharmaceuticals Inc.

Frankfurt - Frankfurt Delayed Price. Currency in EUR

Medexus Pharmaceuticals Inc.

1 Place du Commerce
Suite 225
Verdun, QC H3E 1A2

IndustryDrug Manufacturers - Specialty & Generic
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Sylvain ChretienPres & DirectorN/AN/A1964
Mr. Roland BoivinChief Financial OfficerN/AN/AN/A
Mr. Richard LabelleVP of Sales & MarketingN/AN/AN/A
Mr. Benoît HébertVP of Bus. Devel. & LicensingN/AN/A1968
Mr. Normand ChartrandConsultantN/AN/A1959
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.


Medexus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. It distributes prescription medicines that are used to treat pathological conditions, which primarily affect children from infancy to 18 years of age; and commercializes non-prescription products, such as non-prescription drugs and medical devices that fulfill unmet medical needs of children. The company was formerly known as Pediapharm Inc. and changed its name to Medexus Pharmaceuticals Inc. in December 2018. Medexus Pharmaceuticals Inc. was incorporated in 2003 and is headquartered in Verdun, Canada.

Corporate Governance

Medexus Pharmaceuticals Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.